Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2011-10-18
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235200, C514S586000, C514S303000, C514S314000, C514S317000, C514S318000, C514S326000, C544S129000, C544S360000, C546S118000, C546S176000, C546S194000, C546S201000, C546S225000
Reexamination Certificate
active
08039490
ABSTRACT:
The present invention relates to compounds of the general formulaas dual modulators of the 5-HT2aand D3receptors useful against CNS disorders, wherein A, R1, R2, n, p, q and r are as defined in the specification.
REFERENCES:
patent: 4024264 (1977-05-01), Bjork et al.
patent: 7423050 (2008-09-01), Cohen et al.
patent: 2009/0042943 (2009-02-01), Gobbi et al.
patent: 2536103 (1976-02-01), None
patent: 0 479 601 (1992-04-01), None
patent: 1 348 434 (2003-10-01), None
patent: 03 264579 (1991-11-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO 03/028725 (2003-04-01), None
patent: WO 03/028725 (2003-04-01), None
patent: WO 03/048154 (2003-06-01), None
patent: WO 2004/063181 (2004-07-01), None
Choi et al. “Preparation of phenylalkyl . . . ” CA 138:964344 (2002).
Patani et al. “Bioisosterism . . . ” Chem. Rev. 96, 3147-3176 (1996).
Goldfarb “Method using . . . ” CA 151:92836(2009).
Gabbi et al. “Benzoyl . . . ” CA 147:300997 (2007).
Gobbi et al. “Preparation fo benzoyl piperidine . . . ” CA 150:214184 (2009).
Roth et al., Nat. Rev. Drug Discov. vol. 3, pp. 353-359 (2004).
Lieberman, et al., N. Engl. J. Med. vol. 353, pp. 1209-1223 (2005).
Missale, et al., Physiol. Rev. vol. 78, pp. 189-225 (1998).
Gurevic et al., Neuropsychopharmacology, vol. 20, pp. 60-80 (1998).
Joyce et al., Drug Discovery Today, vol. 10, No. 13 pp. 917-925 (2005).
Gurevic et al., Arch. Gen. Psychiatry, vol. 54, pp. 225-232 (1997).
Leikin J. et al., Med. Toxicol. Adverse Drug Exp. vol. 4, pp. 324-350 (1989).
Harrison, P. J., Br. J. Psychiatry Suppl. 174, vol. 38, pp. 12-22 (1999).
Barnes, et al., Neuropharmacology, vol. 38, pp. 1083-1152 (1999).
Pompeiano et al., Molecular Brain Research vol. 23, pp. 163-178 (1994).
Pazos et al., Neuroscience vol. 21, pp. 123-139 (1987).
Roth et al., Pharmacol. Ther. vol. 79 pp. 231-257 (1998).
Spurlock et al., Mol. Psychiatry, vol. 3 pp. 42-49 (1998).
Arranz et al., Lancet vol. 355, pp. 1615-1616 (2000).
Porras et al., Neuropsychopharmacology, vol. 26, pp. 311-324 (2002).
De Angelis, Curr. Opin. Investig. Drugs vol. 3, pp. 106-112 (2002).
Meltzer et al., J. Pharmacol. Exp. Ther. vol. 251, pp. 238-246 (1989).
Reavill et al., J. Pharmacol. Exp. Ther. vol. 294 pp. 1154-1165 (2000).
Vorel et al., J. Neurosci. vol. 22, pp. 9595-9603 (2002).
Campos et al., Soc. Neurosci. Online Abstract 322.8 (2003).
Ashby et al., Synapse, vol. 48, pp. 154-156 (2003).
Drescher. et al., Am. Soc. Neurosci. Online Abstract 894.6 (2002).
Wustrow et al., Journal of Medicinal Chem. vol. 41, pp. 760-771 (1998).
Tokuyama et al., Synthesis, vol. 8, pp. 1121-1123 (2002).
Bernacka et al., Tetrahedron Letters, vol. 42 pp. 5093-5094 (2001).
Mancuso, A. et al., Synthesis, pp. 165-185 (1981).
Herndon, J.L., et al., Journal of Medicinal Chemistry, vol. 35, pp. 4903-4910 (1992), XP000941731.
Watanabe, Y., et al., Chemical and Pharmaceutical Bulletin, vol. 38, No. 10, pp. 2726-2732 (1990), XP001018922.
Gobbi Luca
Jaeschke Georg
Luebbers Thomas
Roche Olivier
Rodriguez Sarmiento Rosa Maria
Chang Celia
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Benzoyl-piperidine derivatives as dual modulators of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoyl-piperidine derivatives as dual modulators of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoyl-piperidine derivatives as dual modulators of the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4263732